Chief Scientific Officer
Previously, he managed pre-clinical development activities at Viron Therapeutics Inc. (London, Canada) and led specific GPCRs target validation activities at Astra Pain Control AB (Södertälje, Sweden, and Montreal, Canada). He has directed research activities for four products which advanced into clinical development. Graeme received a Ph.D. from McGill University (Montreal, Canada) and is author of over 50 publications and research abstracts, including nine patents and five IND filings. Previously, Graeme was V.P., Drug Discovery at Tranzyme Pharma (RTP, North Carolina, and Sherbrooke, Canada) where he led the discovery and pre-clinical development activities for a pipeline of GPCRs small molecule programs.